Evidence map›Paper›PMID 36297316›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Xin Yang, Long Wang, Jing Zeng, Anguo Wu, Mi Qin, Min Wen, Ting Zhang, Wang Chen, Qibing Mei, Dalian Qin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Xin YangSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Long WangSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Jing ZengSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.ORCID 0000-0003-0857-2217
Anguo WuSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.ORCID 0000-0003-4688-6081
Mi QinSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Min WenSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Ting ZhangSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Wang ChenSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Qibing MeiSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Dalian QinSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Jing YangSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Yu JiangSchool of Graduate, Southwest Medical University, Luzhou 646000, China.
Jianming WuSchool of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China.ORCID 0000-0002-6136-7469
Southwest Medical University · CN

Funding

National Natural Science Foundation of China 82074129
6 · The paper itself

Abstract

Thrombocytopenia is one of the most common complications of cancer therapy. Until now, there are still no satisfactory medications to treat chemotherapy and radiation-induced thrombocytopenia (CIT and RIT, respectively).

Indexed as

Caulis Polygoni MultiflorimegakaryopoiesisMEK/ERKPI3K/Aktthrombocytopeniathrombopoiesis

Identifiers

PMID36297316
PMCPMC9607024
OpenAlexW4297521491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.